Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Jan 3;11(2):85-90.
doi: 10.1007/BF00562897.

Relationship between plasma concentrations and pharmacological effects of labetalol

Relationship between plasma concentrations and pharmacological effects of labetalol

D A Richards et al. Eur J Clin Pharmacol. .

Abstract

In healthy normal subjects following the administration of labetalol the pharmacological effects were measured and compared with the plasma concentrations achieved. The inhibition of exercise induced tachycardia and inhibition of exercise induced increases in systolic pressure were significantly related to the administered dose of labetalol. Labetalol was rapidly absorbed from the gastrointestinal tract and peak plasma concentrations occurred two hours after oral administration. There was a linear correlation (r = 0.84) between the logarithm of the plasma concentration and the maximum inhibition of exercise tachycardia at two hours. After intravenous administration there was an immediate reduction in systolic and diastolic blood pressure with a concomitant small increase in heart rate. There was a rapid decline in the associated plasma concentration but the pharmacological effects were maintained in excess of two hours. Our findings are consistent with those of others who have studied the relationship between pharmacological events and plasma concentrations after single doses of other adrenoceptor blocking drugs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):695-710 - PubMed
    1. Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112-20 - PubMed
    1. Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):367-72 - PubMed
    1. Lancet. 1964 Feb 8;1(7328):296-300 - PubMed
    1. Int Z Klin Pharmakol Ther Toxikol. 1968;1(6):467-74 - PubMed

MeSH terms

LinkOut - more resources